|
T3977 |
Lifitegrast
|
SHP-606,SAR 1118 |
Integrin
|
|
Lifitegrast (SAR 1118) is a lymphocyte, function-associated antigen-1 antagonist. |
|
T7423 |
Diquafosol tetrasodium
|
INS365 |
P2Y Receptor
|
|
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium (INS365) improves tear film stability and visual function, as a topical treatment of dr... |
|
T28496 |
R-932348 choline
|
R-932348,R 348,R 932348,R932348,R-348,R348 |
|
|
R-932348 choline, a dual JAK/SYK inhibitor, is used potentially for treatment of dry eye disease. |
|
T39293 |
Tivanisiran
|
SYL1001,Tivanisiran |
|
|
Tivanisiran (SYL1001) is a siRNA developed specifically to inhibit the expression of transient receptor potential vanilloid 1 (TRPV1) to explore its implications in dry eye disease research. |
|
T70346 |
TOP1362
|
|
|
|
TOP1362 is a Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. TOP1362 strongly inhibited the kinase targets p38α, Syk, Src, and Lck, bloc... |
|
T79235 |
JAK-IN-30
|
|
JAK
|
|
JAK-IN-30 (compound 31) is a water-soluble inhibitor of Janus kinases (JAKs), demonstrating inhibitory potency with half-maximal inhibitory concentration (IC50) values of 2 nM for JAK2, 15 nM for JAK1, 18 nM for JAK3, an... |
